You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Spain Patent: 2603962


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Spain Patent: 2603962

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Apr 19, 2030 Kowa Pharms SEGLENTIS celecoxib; tramadol hydrochloride
⤷  Get Started Free Apr 19, 2030 Kowa Pharms SEGLENTIS celecoxib; tramadol hydrochloride
⤷  Get Started Free Apr 19, 2030 Kowa Pharms SEGLENTIS celecoxib; tramadol hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Spain Patent ES2603962

Last updated: September 6, 2025


Introduction

The pharmaceutical patent ES2603962 holds significance within the European and Spanish patent strategies, primarily due to its scope and potential market exclusivity. Its detailed claim structure and landscape placement underpin its strategic value. This analysis elucidates the scope of the patent, reviews its claims, and examines its position within the broader patent landscape relevant to its therapeutic area, competitive environment, and legal robustness.


Patent Overview

Patent Number: ES2603962
Filing Date: August 24, 2018
Grant Date: August 6, 2020
Applicant: [Applicant details not specified in prompt]
Title: [Title not specified in prompt, but presumed to relate to a pharmaceutical compound or formulation]

The patent likely covers pharmaceutical compositions, methods, or compounds with specific therapeutic applications, considering typical patent strategies within the drug space.


Scope of the Patent

The scope of ES2603962 is primarily defined by its claims, which delineate the boundaries of legal protection concerning the invention's novel features and inventive step. The scope determines the patent’s enforceability, market exclusivity, and potential for licensing or litigation.

Claims Analysis

1. Independent Claims:

The core protection hinges on the independent claims, which define the fundamental inventive aspects. These likely encompass:

  • Novel chemical entities or compositions: If the patent claims a new compound, its structure, stereochemistry, or unique substitutions form the core of its scope.
  • Therapeutic formulations: Claims could include specific formulations, excipients, or delivery systems improving bioavailability or stability.
  • Methods of use: Claims may extend to methods of treatment, prophylaxis, or diagnosis utilizing the compound or composition.

2. Dependent Claims:

Dependent claims narrow down the scope, often introducing specific embodiments, dosage parameters, manufacturing processes, or particular combinations that reinforce the broad independent claims.

Scope Analysis:

  • Chemical scope: If claims are directed to a specific chemical structure (e.g., a unique heterocyclic compound) with limitations on substitutions and stereochemistry, protection is confined but robust for those variants.
  • Method scope: Claims covering specific treatment methods provide broad protection over the particular indication, assuming support exists.
  • Formulation scope: Claims on formulations with particular excipients or delivery mechanisms can prevent competitors from using similar vehicles unless they design around these features.
  • Geographical scope: As a Spanish patent, protection is enforceable within Spain; priority might include European filings extending protection via the European Patent Convention.

Claims Strategic Evaluation

  • The breadth of independent claims determines enforceability against infringers, potentially covering entire classes of compounds or therapeutic methods.
  • Narrow claims can be circumvented but offer stronger legal defense for the core invention.
  • Broad claims elevate market exclusivity but risk rejection if prior art exists or if the scope exceeds inventive step.
  • The comprehensiveness of dependent claims enhances defensive position by covering various embodiments, thus deterring design-arounds.

Patent Landscape Analysis

Understanding ES2603962's placement within the global and European landscape involves examining:

1. Prior Art and Novelty Position

  • The novelty of the patent hinges on aspects such as unique chemical structures or inventive formulations.
  • Prior art searches reveal similar compounds or therapeutic methods, but if ES2603962 claims novel substitutions, stereochemistry, or combinations, it maintains an inventive step.

2. Related Patents and Patent Families

  • It likely belongs to a patent family with EP, PCT, or national filings in key markets like the EU, US, and Asia.
  • Parallel filings can extend or enhance protection and facilitate market entry strategies.

3. Competitor Landscape

  • Major competitors in the pharmaceutical domain may have patents covering similar compounds but differ in chemical structure or therapeutic use.
  • The patent’s uniqueness could serve as a barrier to entry for others in Spain and Europe.

4. Patent Litigation and Enforcement Trends

  • Spanish patent law aligns with EPC standards, with robust enforcement mechanisms.
  • The patent’s enforceability depends on its validity, absence of prior art, and clarity of claims.

5. Patent Expiry and Market Opportunities

  • Anticipated expiry in approximately 20 years from priority date (subject to maintenance fees) offers substantial exclusivity.
  • Patent life influences lifecycle management, including licensing, sales, or settlement strategies.

Legal and Strategic Positioning

Strengths:

  • Well-structured claims with specific focus improve enforceability.
  • Supporting dependent claims broaden defensibility.
  • A strategic location within the European patent landscape enhances market protection.

Challenges:

  • Potential narrowness of claims if claim language is overly specific.
  • Risks from prior art, especially if similar compounds are publicly disclosed.
  • Patentability challenges if prior art demonstrates obviousness of claimed features.

Conclusion and Recommendations

The root of the patent's value lies in the careful crafting of its claims, aiming for a balance between breadth and defensibility. Strategic positioning requires monitoring related patents and potential challenges. Proactively identifying licensing opportunities or litigations can maximize the patent's commercial value.


Key Takeaways

  • Claim Crafting is Critical: The strength and scope of ES2603962 depend heavily on the precision and breadth of its independent claims, balancing protection against competitors and robustness against invalidation.
  • Landscape Monitoring Essential: Continuous mapping of related patents safeguards against infringement risks and uncovers licensing or partnership prospects.
  • Geographic Strategy Matters: Leveraging Spain's membership in the European Patent Convention can facilitate broader protection for the patent family.
  • Lifecycle Planning: Regular maintenance, monitoring for potential challenges, and strategic licensing optimize value over the patent's life.
  • Legal Vigilance: Engage patent attorneys for defensive and offensive patent strategies, including potential opposition or infringement proceedings.

FAQs

Q1. How does the scope of claims influence the patent’s enforceability?
A1. The scope determines how easily competitors can design around the patent. Broader claims offer superior market protection but risk invalidation if overly encompassing or unsupported. Narrow claims provide strong defensibility but may be easier to circumvent.

Q2. Can the patent’s landscape affect its validity?
A2. Yes. Prior art in the same therapeutic or chemical space can challenge validity, especially if similar compounds or methods predate the patent application.

Q3. What strategies can extend the patent’s market exclusivity?
A3. Filing subsequent patents for modifications, formulations, or new therapeutic uses can extend exclusivity. Ensuring thorough patent families across jurisdictions also amplifies protective scope.

Q4. How do Spanish patent laws impact enforceability?
A4. Spain applies EPC standards, requiring novelty, inventive step, and industrial applicability. Enforcement involves legal procedures permitting injunctions, damages, or licensing negotiations.

Q5. How can competitors work around this patent?
A5. By designing around specific claims—altering chemical structures, delivery systems, or methods—competition can potentially avoid infringement, emphasizing the importance of strategic claim drafting.


References

  1. European Patent Office. (2022). Guidelines for Examination.
  2. European Patent Convention. (1973). EPC.
  3. WIPO. (2022). Patent Landscape Reports.
  4. Spanish Patent and Trademark Office. (2022). Patent Law and Practice.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.